Current Regulatory requirements for Registration of Nutraceuticals in India and USA
There is growing recognition of the potential role for nutraceuticals and dietary supplements in helping to reduce health risks and improve health quality. Pharmaceutical and nutritional companies are aware of the monetary success taking advantage of the nutraceuticals and dietary supplements. Nutraceuticals has proven health benefits and their Consumption will keep disease at bay and allow humans to maintain an overall good health. Functional foods and internationally products represent a value added growth opportunity both domestically and internationally. Development of better characterized and research proven products will help enhance consumer confidence in nutraceutical and functional food products in the world. Regulatory aspects of such products were in a state of confusion in 20th century. Till date the regulations are not harmonized for the globe and change from country to country. But now it is clearly understood that the regulations for clinical evidence and safety of such products cannot be less stringent than rules for modern medicines and thus the science of nutraceutical is progressing. The global nutraceutical market will reach $285.0 billion by 2021 from $198.7 billion in 2016 at CAGR of 7.5% from 2016-2021. The present research has been devoted towards better understanding of the nutraceuticals and its regulation in India and USA.
2. Berger MM, Shenkin A. Vitamins and trace elements: Practical aspects of Supplementation. Nutrition. 2006; 22:952-5.
3. Bagchi D.“Nutraceuticals and functional foods regulations in the United States and around the world.” Toxicol 2006; 221:1-3.
4. Ramaa CS, Shirode AR, Mundada AS, Kadam VJ. Nutraceuticals-an emerging era in the treatment and prevention
of cardiovascular diseases. Current Pharm Biotech. 2006;7:15-23.
5. Biesalski HK. “Nutraceuticals: the link between nutrition and medicine” New York:Marcel Dekker Inc; 2001:1-26.
6. Allen LV. Nutritional Products, In: Covington TR, Berardi RR, Young LL, et al. Editors Handbook of Non-prescription Drugs.
Washington DC: American Pharmaceutical Association; 1997.
7. Tyler VE, Foster F. Herbs and phytochemicals, In: Covington TR, Berardi RR, Young LL et al. editors. Handbook
of Non-prescription Drugs. Washington DC: American Pharmaceutical Association; 1996.
8. National Institutes of Health National Center for Complementary and Alternative Medicine. National Center for Complementary
and Integrative Health (NCCIH) [Internet]. Rockville: 2017 Sept [cited 2013 Jan 23]. Available from:
9. Brower V. Nutraceuticals: poised for a healthy slice of the healthcare market? Nat Biotechnol. 1999; 16:728-31.
10. Eskin NAM and Tamir S. Dictionary of Nutraceuticals and Functional Foods. USA:CRC Press, Boca Raton; 2006.
11. Benkouider C “Functional Foods and Nutraceuticals.” 2005; 44:8-11.
12. “The Food Safety and Standards Regulations.” [Internet]. FSSAI; 2011 [cited 2018 Jan 23]. Available from:
13. Food Safety and Standards Authority of India (FSSAI) Act 2006
[Internet]. FSSAI; 2018 [cited 2018 Mar 30]. Available from:
14. Dietary Supplements [Internet]. Drugs control; 2013 Feb [cited 2018 Jan 27]. Available from:
15. Dalmia VP. “Law of Nutritional & Supplemental Food Products in India - The Conflict: Food or Drug?” [Internet]. Mondaq;
2013 Feb 12 [cited 2018 Jan 17]. Available from:
16. U.S Food and Drug Administration. “To Regulate The Safety Of Dietary Supplements” [Internet]. Maryland, United States:
FDA Statutory Authority; 2003 [cited 2018 Jan 24]. Available from:
http://www.crnusa.org/pdfs/CRN-Hutt_WhitePaper_ FDA RegulatesDS_090711.pdf
17. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements [Internet]. Maryland:
US FDA; 2015 Apr 23 [cited 2018 Jan 24]. Available from:
18. Kessler RC, Davis RB, Foster DF, et al. Long Term Trends in the Use of Complementary and Alternative
Medical Therapies in the United States. Ann Intern Med. 2001; 135(4):344-51.
19. Food safety and standards authority of India. Food product standards and Food Additives (Amendment) Regulations
[Internet]. New Delhi, India: FSSAI; 2015 [cited 2018 Jan 11]. Available from:
20. Sharma A, Kumar P, Sharma P, Shrivastav B. A Comparative Study of Regulatory Registration Procedure
of Nutraceuticals in India, Canada and Australia. International Journal of Pharmaceutical Quality Assurance [Internet].
2013 [cited 2013 October 13]; 4(4):61-66. Available from:
21. Functional foods in Japan, Medical Food News, May 1997 No.6 [Internet]. Medicinal food News; 2015 Jul 20
[cited 2018 Jan 10]. Available from:
22. Ohama H, Ikeda H and Moriyama H. Health foods and Foods with health claims in Japan. Toxicology. 2006;(221):95-111
23. Kumar P. A review on nutraceuticals -critical supplement for building a healthyworld. World journal of pharmacy and
pharmaceutical sciences. 2016; 5(3):579-94.
24. Bowmik D. Nutraceutical –A bright scope and opportunity of Indian healthcare market. The pharma innovation journal. 2013;1(11):29-41.
25. Singh MC. Nutraceutical and regulatory scenario. International journals of pharmacy and pharmaceutical sciences. 2013; 5(3):23-36.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM
Rights of Authors:
The International Journal of Drug Regulatory affairs. recognize the retention of the following:
- Patent and trademark rights and rights to any process or procedure described in the article.
- The right to photocopy or make single electronic copies of the article for their own personal use, including for their own classroom use, or for the personal use of colleagues, provided the copies are not offered for sale and are not distributed in a systematic way outside of their employing institution (e.g. via an e-mail list or public file server). Posting of an article on a secure network (not accessible to the public) within the author’s institution is permitted.
- The right, subsequent to publication, to use the article or any part thereof free of charge in a printed compilation of works of their own, such as collected writings or lecture notes.
Note: All copies, paper, electronic or other use, of the information must include an indication of the IJDRA copyright and a full citation of the journal source.
- If the article was prepared jointly with other author(s), the signing author has informed the co-author(s) of the terms of this copyright transfer and is signing on their behalf as their agent and represents that he or she is authorized to do so, then please confirm by checking the appropriate box following the signature line. The signing author shall bear the responsibility for designating the co-author(s) and must inform the IJDRA of any changes in authorship.
- If copyright is held by the employer, then the employer or an authorized representative of the employer must sign. If the author signs, it is understood that this is with the authorization of the employer and the employer’s acceptance of the terms of the transfer.
The author(s) warrant(s) that the article is the author’s original work and has not been published before. The author(s) warrant(s) that the article contains no libelous or other unlawful statements, and does not infringe on the rights of others. If excerpts from copyrighted works are included, the author(s) has (have) obtained or will obtain written permission from the copyright owners and will credit the source in the article.
Preprints: The author(s) must agree that if a prior version of this work (normally a preprint) has been posted to an electronic public server, they will not update and/or replace the prior version in order to make it identical in content to the final published version.